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Background
Mechanical stimulation of bone cells is critical for main-
taining bone mass and strength, and a better understand-
ing of how mechanical stimuli are converted into
intracellular signals to activate an anabolic program in
osteoblasts/cytes is fundamental to improving treatments
for osteo-degenerative diseases [1,2]. Weight bearing and
locomotion stimulate interstitial fluid flow through the
bone canalicular system, and the resultant shear stress is
thought to be a major mechanism whereby mechanical
forces stimulate osteoblast/osteocyte growth and differ-
entiation [1,2]. In primary osteoblasts and osteoblast/
cyte-like cell lines, fluid shear stress induces rapid expres-
sion of c-fos, fra-1, fra-2,a n dfosB/ΔfosB mRNAs [3];
these genes encode transcriptional regulators important
for osteoblast proliferation and differentiation, as demon-
strated by the phenotypes of mice that over-express or
lack these proteins, respectively [4]. We have previously
shown that fluid shear stress increases osteoblast/cyte
nitric oxide (NO) production, leading to increased cGMP
synthesis and activation of cGMP-dependent protein
kinases (PKGs). The NO/cGMP/PKG signaling pathway
is required for shear-induced expression of all four fos
family genes, and induction of these genes is mediated
through activation of the mitogen-activated protein
kinases Erk1/2 [3]. However, molecular mechanisms
leading to Erk activation in shear-stressed osteoblasts are
largely unknown.
Results
We have now defined the events leading from shear stress
activation of NO/cGMP/PKG II to the activation of Src
[5]; we show that this pathway is required for Erk activa-
tion, and controls osteoblast proliferation and survival. We
found a novel link between NO/cGMP/PKG and b3i n t e g -
rins, the key mechano-sensors in bone, and show that
PKG II activates b3-associated Src by activating the tyro-
sine phosphatase Shp-1. PKG II directly phosphorylates
and stimulates Shp-1 activity, which de-phosphorylates a
C-terminal, inhibitory phosphorylation site on Src, leading
to Src activation. Fluid shear stress triggers PKG II, Src,
and Shp-1/2 recruitment to a mechano-sensitive complex
containing b3 integrins, defining a novel “mechanosome”.
We found that PKG II-null mice have defective osteoblast
Src/Erk signaling, decreased Erk-dependent gene expres-
sion in bone, and impaired osteoblast-dependent, mem-
branous bone formation. These results complement
previous studies in PKG II-deficient mice, which showed
defective chondroblast differentiation and endochondral
bone formation, and studies in NO synthase-deficient
mice, which demonstrated an important role of NO in
osteoblast biology [6,7].
Conclusion
Our findings reveal crosstalk between NO/cGMP/PKG
and integrins, establish a new mechanism of Src activation,
and fill a gap in our understanding of how mechanical
forces acting on cell-matrix adhesions are translated into
cellular responses. Since Src controls Erk, a key regulator
of osteoblast growth and survival, our results support
using PKG-activating drugs as mechano-mimetics for
treating osteoporosis.
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